VOLUME 31: NO. 9 SEPTEMBER 2004
Editorials
The No Man's Land of Undifferentiated Inflammatory Polyarthritis
S.A. Paget .........1673
Window of Opportunity
D.E. Furst .........1677
Issues in Investigating the Genetic Epidemiology of Disease Expression
P. Rahman .........1680
The Quest for Explanations for Race/Ethnic Disparity in Rates of Use of Total Joint Arthroplasty
G.A. Hawker .........1683
Articles
Dating the "Window of Therapeutic Opportunity" in Early RA: Accuracy of Patient Recall of Arthritis Symptom Onset
S. Amjadi-Begvand, D. Khanna, G.S. Park, K.J. Bulpitt, W.K. Wong, H.E. Paulus .........1686
Effect of MTX Therapy on BMD and Body Composition in Rat Adjuvant Arthritis
S.L. Morgan, D-T. Chen, J. Carlee, J.E. Baggott .........1693
Connective Tissue Metabolism in Patients with Unclassified Polyarthritis and Early RA. Relationship to Disease Activity, BMD, and Radiographic Outcome
T. Jensen, M. Klarlund, M. Hansen, K.E. Jensen, H. Skjødt, L. Hyldstrup .........1698
Indirect and Total Costs of Early RA: a Randomized Comparison of Combined Step-down Prednisolone, MTX, and Sulfasalazine with Sulfasalazine Alone
I.B.C. Korthals-de Bos, M.W. van Tulder, M. Boers, et al .........1709
Quality of Life and Economic Burden of Illness in Very Early Arthritis. A Population Based Study in Southern Sweden
M.K. Söderlin, H. Kautiainen, T. Skogh, M. Leirisalo-Repo .........1717
Morning Stiffness in Patients with Early RA Is Associated More Strongly with Functional Disability than with Joint Swelling and ESR
Y. Yazici, T. Pincus, H. Kautiainen, T. Sokka .........1723
Risk Factors for MTX-Induced Abnormal Laboratory Monitoring Results in Patients with RA
P.D. Kent, H.S. Luthra, C.J. Michet Jr .........1727
Short Term Whole Body Retention in Relation to Rate of Bone Resorption and Cartilage Degradation after Intravenous Bisphosphonate (Pamidronate) in RA
S.C.L.M. Cremers, M.C. Lodder, J. den Hartigh, et al .........1732
Partner Participation in Cognitive-Behavioral Self-Management Group Treatment for Patients with RA
W. van Lankveld, T. van Helmond, G. Näring, D.J. de Rooij, F. van den Hoogen .........1738
Dyslipoproteinemia in Patients with Active RA: Effects of Disease Activity, Sex, and Menopausal Status on Lipid Profiles
W-H. Yoo .........1746
Utility of Red Amsler Grid Screening in a Rheumatology Clinic
A.C. Pluenneke, P.H. Blomquist .........1754
Angiotensin-Converting Enzyme (Insertion/Deletion) and Endothelial Nitric Oxide Synthase Polymorphisms in Patients with SLE
G. Douglas, C. Reilly, M.A. Dooley, G. Page, G. Cooper, G. Gilkeson .........1756
Increased Incidence of Cervical Intraepithelial Neoplasia in Women with SLE Treated with Intravenous Cyclophosphamide
V.M. Ognenovski, W. Marder, E.C. Somers, C.M. Johnston, J.G. Farrehi, S.M. Selvaggi, W.J. McCune .........1763
Immunogenetic Features in 120 Japanese Patients with Idiopathic Inflammatory Myopathy
T. Furuya, M. Hakoda, N. Tsuchiya, et al .........1768
Concordance of Disease Severity among Family Members with AS?
S. Brophy, S. Hickey, A. Menon, et al .........1775
Measurement of Spinal Mobility in AS: Comparison of Occiput-to-Wall and Tragus-to-Wall Distance
L. Heuft-Dorenbosch, D. Vosse, R. Landewé, et al .........1779
Vascular Endothelial Growth Factor Gene Polymorphisms in Behçet's Disease
C. Salvarani, L. Boiardi, B. Casali, et al .........1785
Surgical Approach for Total Hip Arthroplasty: Direct Lateral or Posterior?
B.M. Jolles, E.R. Bogoch .........1790
Cost-Effectiveness of Treatment Strategies for OA of the Knee in Taiwan
Z-S. Yen, M-S. Lai, C-T. Wang, et al .........1797
Gastroduodenal Safety and Tolerability of Lumiracoxib Compared with Ibuprofen and Celecoxib in Patients with OA
C.C. Hawkey, P. Svoboda, I.F. Fiedorowicz-Fabrycy, et al .........1804
Ethnic Differences in Health Preferences: Analysis Using Willingness-to-Pay
M.M. Byrne, K.J. O'Malley, M.E. Suarez-Almazor .........1811
Assessment of Disease Severity (in Terms of Function) Using the Internet
S. Brophy, T. Hunniford, G. Taylor, A. Menon, T. Roussou, A. Calin .........1819
Deaths from Arthritis and Other Rheumatic Conditions, US, 1979-1998
J.J. Sacks, C.G. Helmick, G. Langmaid .........1823
Pediatric Rheumatology
Determination of Anti-Cyclic Citrullinated Peptide Antibodies in the Sera of Patients with JIA
J.M. Low, A.K. Chauhan, D.A. Kietz, U. Daud, P.H. Pepmueller, T.L. Moore .........1829
Cardiopulmonary Exercise Testing in JIA
G. Metin, L. Öztürk, Ö. Kasapçopur, M. Apelyan, N. Arisoy .........1834
JIA: Parent-Child Discrepancy on Reports of Pain and Disability
T.M. Palermo, K. Zebracki, S. Cox, A.J. Newman, N.G. Singer .........1840
HLA-DRB1*15021 Is the Predominant Allele in Japanese Patients with Juvenile Dermatomyositis
N. Tomono, M. Mori, S. Nakajima, et al .........1847
Case Reports
SLE and Calciphylaxis
S.H. Sakr, E.B. Russell, H.E. Jasin .........1851
Paraneoplastic Polyarthritis in an Ovarian Teratoma
W. Wiese, H. Alansari, P. Tranchida, F. Fernández Madrid .........1854
Multiple Spontaneous Visceral Hematomas Revealing Polyarteritis Nodosa
Y. Allanore, C. Rosenberg, O. Vignaux, et al .........1858
Disseminated Prototheca wickerhamii Infection with Arthritis and Tenosynovitis
J.S. Pascual, L.L. Balos, A.N. Baer .........1861
Images in Rheumatology
Tophaceous Pseudotumors in Polynesian Patients with Gout
L. McLean .........1866
Maxillary Actinomycosis in an Immunocompromised Patient with Longstanding Vasculitis Treated with Mycophenolate Mofetil
I.H. Tarner, A. Schneidewind, H.J. Linde, et al .........1869
Correspondence
Erosions Rare Without Clinically Detectable Inflammation B.M. Rothschild .........1872
Reply T. Sokka, P. Hannonen .........1873
Pollen Allergies in Patients with SLE J. Jiménez-Alonso, J. Jiménez-Jáimez, M.V. Almazán .........1873
Reply J. Pope .........1873
Letters
Synovial Density of Frizzled 5-Positive Cells Does Not Differ Between Patients with RA and OA and Is Independent of Inflammation C. Weidler, J. Schaumburger, L.E. Miller, J. Schölmerich .........1874
Septicemia with S. aureus, ß-Hemolytic Streptococci Group B and G, and E. coli in a Patient with RA Treated with a Recombinant Human IL-1 Receptor Antagonist (Anakinra) C. Turesson, K. Riesbeck .........1876
Notices